These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 8789431)
1. Comparative study of systemic interferon alfa-2a with oral isotretinoin and oral isotretinoin alone in the treatment of recurrent condylomata accuminata. Cardamakis EK; Kotoulas IG; Dimopoulos DP; Stathopoulos EN; Michopoulos JT; Tzingounis VA Arch Gynecol Obstet; 1996; 258(1):35-41. PubMed ID: 8789431 [TBL] [Abstract][Full Text] [Related]
2. Comparative study of systemic interferon alfa-2a plus isotretinoin versus isotretinoin in the treatment of recurrent condyloma acuminatum in men. Cardamakis E; Kotoulas IG; Relakis K; Metalinos K; Michopoulos J; Stathopoulos E; Mantouvalos H Urology; 1995 May; 45(5):857-60. PubMed ID: 7747375 [TBL] [Abstract][Full Text] [Related]
3. Comparative study of systemic interferon alfa-nl and isotretinoin in the treatment of resistant condylomata acuminata. Olsen EA; Kelly FF; Vollmer RT; Buddin DA; Weck PK J Am Acad Dermatol; 1989 Jun; 20(6):1023-30. PubMed ID: 2754052 [TBL] [Abstract][Full Text] [Related]
4. A comparison of interferon alfa-2a and podophyllin in the treatment of primary condylomata acuminata. The Condylomata International Collaborative Study Group. Genitourin Med; 1991 Oct; 67(5):394-9. PubMed ID: 1743712 [TBL] [Abstract][Full Text] [Related]
5. A case of condyloma acuminatum treated successfully with low-dose isotretinoin and interferon. Yildirim M; Inaloz HS; Baysal V; Kesici D; Candir O Int J Clin Pract; 2004 Sep; 58(9):889-91. PubMed ID: 15529524 [TBL] [Abstract][Full Text] [Related]
6. Recurrent condylomata acuminata treated with recombinant interferon alpha-2a. A multicenter double-blind placebo-controlled clinical trial. Condylomata International Collaborative Study Group. Acta Derm Venereol; 1993 Jun; 73(3):223-6. PubMed ID: 8105627 [TBL] [Abstract][Full Text] [Related]
7. Recurrence of condylomata acuminata following cryotherapy is not prevented by systemically administered interferon. Eron LJ; Alder MB; O'Rourke JM; Rittweger K; DePamphilis J; Pizzuti DJ Genitourin Med; 1993 Apr; 69(2):91-3. PubMed ID: 8509099 [TBL] [Abstract][Full Text] [Related]
8. Systemic treatment of extensive condylomata acuminata with interferon alfa-2b. Grablowitz D; Micksche M; Söltz-Szöts J J Am Acad Dermatol; 1992 Jun; 26(6):1009-10. PubMed ID: 1607400 [No Abstract] [Full Text] [Related]
14. Recurrent condylomata acuminata treated with recombinant interferon alfa-2a. A multicenter double-blind placebo-controlled clinical trial. Condylomata International Collaborative Study Group. JAMA; 1991 May 22-29; 265(20):2684-7. PubMed ID: 2023348 [TBL] [Abstract][Full Text] [Related]
15. Intralesional interferon alfa-2b treatment of condylomata acuminata previously resistant to podophyllum resin application. Boot JM; Blog FB; Stolz E Genitourin Med; 1989 Jan; 65(1):50-3. PubMed ID: 2921053 [TBL] [Abstract][Full Text] [Related]
16. Randomized phase II/III trial of interferon Alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell Carcinoma: the European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951). Aass N; De Mulder PH; Mickisch GH; Mulders P; van Oosterom AT; van Poppel H; Fossa SD; de Prijck L; Sylvester RJ J Clin Oncol; 2005 Jun; 23(18):4172-8. PubMed ID: 15961764 [TBL] [Abstract][Full Text] [Related]
17. Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma. Motzer RJ; Murphy BA; Bacik J; Schwartz LH; Nanus DM; Mariani T; Loehrer P; Wilding G; Fairclough DL; Cella D; Mazumdar M J Clin Oncol; 2000 Aug; 18(16):2972-80. PubMed ID: 10944130 [TBL] [Abstract][Full Text] [Related]